1. Home
  2. BIOX vs ALLR Comparison

BIOX vs ALLR Comparison

Compare BIOX & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioceres Crop Solutions Corp.

BIOX

Bioceres Crop Solutions Corp.

HOLD

Current Price

$0.37

Market Cap

23.7M

Sector

Industrials

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.03

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIOX
ALLR
Founded
2001
2004
Country
Argentina
United States
Employees
751
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
19.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
BIOX
ALLR
Price
$0.37
$1.03
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$4.33
★ $9.75
AVG Volume (30 Days)
★ 546.5K
104.3K
Earning Date
05-19-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$37.82
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.30
$0.77
52 Week High
$2.19
$1.84

Technical Indicators

Market Signals
Indicator
BIOX
ALLR
Relative Strength Index (RSI) 40.18 33.04
Support Level $0.32 $1.03
Resistance Level $0.40 $1.08
Average True Range (ATR) 0.04 0.10
MACD -0.01 -0.02
Stochastic Oscillator 30.49 8.24

Price Performance

Historical Comparison
BIOX
ALLR

About BIOX Bioceres Crop Solutions Corp.

Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States. It is focused on the clinical development of its lead program: Stenoparib, which is being co-developed with a drug specific DRP companion diagnostic.

Share on Social Networks: